# Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

> **NCT02924324** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 56 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **DEVICE:** propofol
- **DRUG:** ropivacaine
- **BEHAVIORAL:** Wong-Baker FACES® Pain Rating Scale
- **BEHAVIORAL:** Post-procedural quality of life (QOL)

## Key facts

- **NCT ID:** NCT02924324
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02924324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02924324, "Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02924324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*